PPAR AgonistEnduranceFat LossMetabolismPerformance

Cardarine (GW 501516)

What is Cardarine (GW 501516)?

Cardarine (GW 501516) is a PPARδ agonist (NOT a SARM) that activates peroxisome proliferator-activated receptor delta, influencing fatty acid metabolism and endurance. It encourages the body to use fat rather than carbohydrates as primary fuel. CRITICAL WARNING: Animal studies found Cardarine caused rapid, aggressive cancer development in multiple organs (liver, thyroid, stomach, testes), leading to halted development in 2007. It is banned by WADA and NOT approved for human use. Despite purported benefits, the cancer risk makes it highly dangerous.

Benefits

  • Enhanced Endurance and Stamina
  • Increased Fat Burning
  • Improved Lipid Profiles (HDL↑ LDL↓)
  • Better Glucose Metabolism
  • Potential Cardiovascular Protection

Typical Dosage

  • Anecdotal: 10-20mg daily
  • 8-12 week cycles (NOT RECOMMENDED)

Side Effects

  • CANCER (multiple organ types in animals)
  • Potential liver damage
  • Cardiovascular problems
  • Muscle cramps
  • Joint pain

Negative Interactions

  • EXTREME CANCER RISK - animal studies showed rapid tumor growth
  • Banned substance (WADA)
  • NOT FDA approved
HomeLibraryResearchFavoritesToolsVisuals